Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.
作者信息
van Gelder T, Zietse R, Yzermans J N, Rischen-Vos J, Vaessen L M, Weimar W
机构信息
Department of Internal Medicine, University Hospital Rotterdam, The Netherlands.